Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001370053-25-000089
Filing Date
2025-11-04
Accepted
2025-11-04 16:19:08
Documents
74
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q anab-20250930.htm   iXBRL 10-Q 1518829
2 EX-31.1 anab-9302025x10qxexx311.htm EX-31.1 8344
3 EX-31.2 anab-9302025x10qxexx312.htm EX-31.2 8199
4 EX-32.1 anab-9302025x10qxexx321.htm EX-32.1 4889
5 EX-32.2 anab-9302025x10qxexx322.htm EX-32.2 4786
11 PIPELINE CHART anab-20250930_g1.jpg GRAPHIC 91133
  Complete submission text file 0001370053-25-000089.txt   8143016

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20250930.xsd EX-101.SCH 62206
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20250930_cal.xml EX-101.CAL 56342
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20250930_def.xml EX-101.DEF 257274
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20250930_lab.xml EX-101.LAB 692423
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20250930_pre.xml EX-101.PRE 476071
77 EXTRACTED XBRL INSTANCE DOCUMENT anab-20250930_htm.xml XML 1182496
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37985 | Film No.: 251449380
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)